MedTrace Logo

An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)

NCT05638815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2023-11-22

No results posted yet for this study

Summary

The study is a multi-center, observational study to evaluate the feasibility of α-synuclein-related biomarkers and imaging data in the disease diagnosis and prognosis evaluation in Synucleinopathies and healthy subjects.

Conditions

Sponsors & Collaborators

  • SciNeuro

    lead INDUSTRY

Principal Investigators

  • Shengdi Chen, MD,PHD · Neurology Department in Ruijin Hospital Shanghai JiaoTong University School of Medicine

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-23
Primary Completion
2023-07-10
Completion
2023-07-10

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05638815 on ClinicalTrials.gov